Opportunity Information: Apply for CDC RFA CK10 1001
Apply for CDC RFA CK10 1001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Creutzfeldt Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Apr 5, 2010 and posted on Apr 5, 2010.
- Applicants must submit their applications by Jun 4, 2010 Letter of Intent Deadline April 19, 2010 Application Deadline June 4, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $325,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $65,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Universities Colleges Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA CK10-1001) is a Centers for Disease Control and Prevention cooperative agreement focused on Creutzfeldt-Jakob Disease (CJD) and other human prion diseases, with an emphasis on strengthening support for affected families while also improving national surveillance. The core idea is to bridge practical, real-world needs that families face during suspected or confirmed prion disease cases with the public health need to track CJD trends, recognize emerging variants, and improve the evidence base needed for faster recognition and response. The announcement also notes alignment with the Healthy People 2010 focus area of Infectious Diseases, framing prion disease work as part of broader national infectious disease readiness even though prion diseases are distinct from typical bacterial or viral infections.
The program lays out four main goals. First, it aims to give family members of patients with suspected or diagnosed prion disease easy access to consultation from people who are experienced and knowledgeable about the practical issues surrounding CJD. In practice, this means helping families navigate the disease trajectory, communication with clinicians, handling of personal and medical decisions, and the complex logistical and emotional issues that can come with a rapidly progressive, fatal neurodegenerative condition. Second, the opportunity seeks to facilitate educational and mutually beneficial interaction between researchers and family members of CJD patients. That point is important because it suggests a two-way exchange: families gain clearer information and guidance, while researchers and surveillance programs gain insights, participation, case information, and stronger relationships that can improve the quality and completeness of public health data. Third, the program explicitly targets increased general awareness about CJD, implying public-facing education and outreach to raise understanding among communities and potentially among healthcare professionals as well. Fourth, it aims to increase the number of autopsies performed in suspected CJD cases, which is a major surveillance and diagnostic priority because definitive confirmation and prion typing often rely on postmortem evaluation, and improved autopsy rates directly strengthen national understanding of incidence, subtypes, and possible variant cases.
From an administrative standpoint, the funding instrument is a cooperative agreement, which typically means the CDC expects to have substantial involvement with the awardee compared to a standard grant. The activity category is Health, and the CFDA number listed is 93.283 (CDC Investigations and Technical Assistance). The CDC anticipated making one award, with an estimated total funding amount of $325,000. The award ceiling is listed as $65,000, and the award floor is $0, indicating the maximum amount per budget period or per award action as specified in the announcement data. There is no cost sharing or matching requirement, which lowers barriers for organizations that may not have large unrestricted funds to contribute.
The timeline in the source data shows the opportunity was posted on April 5, 2010, with an original and current closing date of June 4, 2010, and an archive date of July 4, 2010. A letter of intent deadline is shown (April 29, 2010 in one line and April 19, 2010 in another), while the application deadline is consistently June 4, 2010. For applicants, those dates signal a relatively short turnaround window and the likelihood that CDC wanted applicants ready to move quickly on established education, family support, and surveillance-support activities.
Eligibility is broad and includes many types of public and nonprofit entities. Eligible applicants include nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in that nonprofit category), universities and colleges, community-based and faith-based organizations, federally or state recognized American Indian/Alaska Native tribal governments, tribally designated organizations, Urban Indian health organizations, tribal epidemiology centers, and state and local governments and their bona fide agents. The announcement also clarifies that political subdivisions of states may apply in consultation with states. For entities applying as a bona fide agent on behalf of a state or local government, documentation is required: a letter from the state or local government confirming bona fide agent status must be attached in the application package (uploaded with the other attachment forms through Grants.gov). This wide eligibility pool suggests CDC was open to partnering with organizations that already have direct relationships with affected families, clinical and research networks, or established public health education capacity.
The practical impact of the work CDC is trying to fund can be summarized as a combined family-support and surveillance-strengthening initiative. By improving access to knowledgeable consultation and creating structured ways for families and researchers to interact, the program aims to reduce confusion and isolation for families while also making surveillance more complete and scientifically useful. Increasing public awareness can help with earlier recognition of symptoms and more informed engagement with healthcare systems. Finally, boosting autopsy rates directly improves diagnostic certainty and the ability to detect emerging prion disease variants, which is central to national situational awareness.
For questions or technical issues accessing the full announcement, the listed contact is the CDC Procurement and Grants Office TIMS, with phone number 770-488-2700 and email PGOTIM@cdc.gov.
Frequently Asked Questions (FAQs): CDC RFA CK10-1001 (CJD and Human Prion Diseases)
What is this funding opportunity?
This opportunity (CDC RFA CK10-1001) is a Centers for Disease Control and Prevention (CDC) cooperative agreement focused on Creutzfeldt-Jakob Disease (CJD) and other human prion diseases. The effort combines two priorities: (1) strengthening practical support for families dealing with suspected or confirmed prion disease cases, and (2) improving national public health surveillance for CJD trends, emerging variants, and better evidence for faster recognition and response.
What is the main purpose of the program?
The program is designed to bridge real-world family needs during suspected or confirmed prion disease cases with the public health need to track and understand CJD nationally. The emphasis is on helping families access knowledgeable consultation while also strengthening surveillance quality and completeness.
What are the main goals of the program?
The opportunity lays out four main goals:
- Provide family members of patients with suspected or diagnosed prion disease easy access to consultation from experienced, knowledgeable people about practical issues surrounding CJD.
- Facilitate educational and mutually beneficial interaction between researchers and family members of CJD patients.
- Increase general awareness about CJD.
- Increase the number of autopsies performed in suspected CJD cases.
How does the program support families affected by suspected or confirmed prion disease?
The program emphasizes making it easier for family members to access consultation from people familiar with the practical issues around CJD. This can include help navigating the disease trajectory, communicating with clinicians, handling personal and medical decisions, and managing complex logistical and emotional challenges associated with a rapidly progressive and fatal neurodegenerative condition.
What does "educational and mutually beneficial interaction" between families and researchers mean?
Based on the description, it is intended to be a two-way exchange. Families can receive clearer information and guidance, while researchers and surveillance programs may gain insights, case information, participation, and improved relationships that can strengthen the quality and completeness of public health data.
Why does the program include a goal about increasing general awareness of CJD?
The opportunity explicitly targets increased general awareness of CJD, implying education and outreach efforts aimed at improving understanding among the public and potentially healthcare professionals. Higher awareness can support earlier recognition of symptoms and more informed engagement with healthcare systems.
Why is increasing autopsies in suspected CJD cases a key goal?
Autopsies are described as a major surveillance and diagnostic priority because definitive confirmation and prion typing often rely on postmortem evaluation. Increasing autopsy rates strengthens national understanding of incidence, subtypes, and the detection of possible emerging or variant prion disease cases.
What kind of funding mechanism is being used?
The funding instrument is a cooperative agreement. This typically indicates that CDC expects to have substantial involvement with the awardee compared to a standard grant.
Which agency is offering this opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What is the activity category and CFDA number for this opportunity?
The activity category is Health. The CFDA number listed is 93.283 (CDC Investigations and Technical Assistance).
How many awards did CDC expect to make?
CDC anticipated making one award.
What is the estimated total funding amount?
The estimated total funding amount is $325,000.
What are the award ceiling and award floor?
The award ceiling is listed as $65,000, and the award floor is $0, indicating the maximum and minimum amounts per budget period or per award action as presented in the opportunity data.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was the opportunity posted and when did it close?
The opportunity was posted on April 5, 2010. The original and current closing date is June 4, 2010. The archive date is July 4, 2010.
Was a letter of intent required, and when was it due?
A letter of intent deadline is shown, but the information provided includes two different dates: April 29, 2010 in one line and April 19, 2010 in another. The application deadline is consistently listed as June 4, 2010.
What is the application deadline?
The application deadline is June 4, 2010.
Who is eligible to apply?
Eligibility is broad and includes:
- Nonprofits with or without 501(c)(3) status (in the nonprofit category specified as not institutions of higher education)
- Universities and colleges
- Community-based and faith-based organizations
- Federally or state recognized American Indian/Alaska Native tribal governments
- Tribally designated organizations
- Urban Indian health organizations
- Tribal epidemiology centers
- State and local governments and their bona fide agents
Can political subdivisions of states apply?
Yes. The announcement notes that political subdivisions of states may apply in consultation with states.
What is a "bona fide agent," and is documentation required?
The opportunity states that state and local governments and their bona fide agents are eligible. If an entity applies as a bona fide agent on behalf of a state or local government, documentation is required: a letter from the state or local government confirming bona fide agent status must be attached in the application package and uploaded with the other attachment forms through Grants.gov.
How does this opportunity relate to Healthy People 2010?
The announcement notes alignment with the Healthy People 2010 focus area of Infectious Diseases. It frames prion disease work as part of broader national infectious disease readiness, even though prion diseases are distinct from typical bacterial or viral infections.
What is the overall expected impact of the funded work?
The described impact is a combined family-support and surveillance-strengthening initiative: improved access to knowledgeable consultation for families, structured interaction between families and researchers, increased public awareness, and increased autopsy rates to strengthen diagnostic certainty and national situational awareness.
Who do we contact for questions or technical issues accessing the full announcement?
The listed contact is the CDC Procurement and Grants Office TIMS. Phone: 770-488-2700. Email: PGOTIM@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: OVC FY 10 NCVRW Community Awareness Projects
Previous opportunity: BJA FY 10 National Initiatives Enhancing Law Enforcement and Crime Prevention
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CK10 1001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CK10 1001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Non Communicable Disease Prevention and Health Promotion Apply for CDC RFA DP10 1010 Funding Number: CDC RFA DP10 1010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34) Apply for PAR 10 163 Funding Number: PAR 10 163 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| National Center for Chronic Disease Prevention and Health Promotion, Division of Oral Health Apply for CDC RFA DP10 1018E Funding Number: CDC RFA DP10 1018E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Charcot Marie Tooth Resource Center Apply for CDC RFA DD10 1014 Funding Number: CDC RFA DD10 1014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Tanzania Capacity and Communications Project (TCCP) Apply for USAID TANZANIA 10 006 RFA Funding Number: USAID TANZANIA 10 006 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $45,000,000 |
| Teenage Pregnancy Prevention Research and Demonstration Programs (Tier 2) and Personal Responsibility Education Program Apply for AH TP2 10 001 Funding Number: AH TP2 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34) Apply for RFA HL 11 009 Funding Number: RFA HL 11 009 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Effective Strategies to Reduce Motor Vehicle Injuries Among American Indians/Alaska Natives Apply for CDC RFA CE10 1001 Funding Number: CDC RFA CE10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $70,000 |
| Integrating HIV Care and Treatment within the Network of Facilities Offering TB Treatment and Providing Technical Assistance to the Ministry of Health Toward Strengthening the National TB/HIV System in Haiti Under the President s Emergency Plan for A Apply for CDC RFA PS10 1011 Funding Number: CDC RFA PS10 1011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Health Careers Opportunity Program Apply for HRSA 10 119 Funding Number: HRSA 10 119 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 10 014 Funding Number: SM 10 014 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| The NEI Mentored Clinical Scientist Development Program Award (K12) Apply for PAR 10 166 Funding Number: PAR 10 166 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fetal Alcohol Spectrum Disorders Apply for HRSA 10 034 Funding Number: HRSA 10 034 Agency: Health Resources and Services Administration Category: Health Funding Amount: $478,000 |
| Knowledge Synthesis Center for Evaluating Genomic Application in Practice and Prevention (U18) Apply for RFA GD 10 001 Funding Number: RFA GD 10 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| FY10 Announcement of Availability of Funds for Adolescent Family Life (AFL) Demonstration Projects Apply for PA APH 10 001 Funding Number: PA APH 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $600,000 |
| Ryan White Part B Supplemental Apply for HRSA 10 165 Funding Number: HRSA 10 165 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Future Competitive Procurement for Regional HIV Prevention Program in Central America and Mexico Apply for RFA 596 10 000001 Funding Number: RFA 596 10 000001 Agency: El Salvador USAID San Salvador Category: Health Funding Amount: $30,000,000 |
| Development and Dissemination of Evidence Based Clinical Care Guidelines for Muscular Dystrophies Apply for CDC RFA DD10 1012 Funding Number: CDC RFA DD10 1012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Addressing Syndemics Through Program Collaboration and Service Integration (PCSI) Apply for CDC RFA PS10 10175 Funding Number: CDC RFA PS10 10175 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Nurse Faculty Loan Program Apply for HRSA 10 142 Funding Number: HRSA 10 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CK10 1001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
